Stoke Therapeutics, Inc.
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Aug…
Government Awards Analysis Beta
It's important to keep an eye on government contracts, because they can make up a substantial portion
of total sales for your researched company.
The Data for the government spending analysis is directly sourced from the
US gov. application interface.
Obligations Over-Time
Stoke Therapeutics, Inc. has no obligation with a government/award agency.
Latest Obligations
Spending By Type
Stoke Therapeutics, Inc. can't present spending by time.
Get PRO Today
With PRO you will unlock all insights related to government awards of Stoke Therapeutics, Inc..